Candriam Equities L Oncology Impact I/ LU1864482515 /
| NAV04/06/2024 | Chg.+8.8101 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,201.1001GBP | +0.40% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | - | 10.22 | 10.74 | 1.48 | -1.69 | 0.14 | 7.21 | -2.22 | 2.49 | 1.44 | - |
| 2021 | 0.09 | -5.90 | 1.24 | 1.97 | -2.18 | 6.26 | -1.59 | 6.66 | -1.78 | 1.68 | -2.99 | 1.57 | +4.39% |
| 2022 | -9.64 | -1.76 | 6.66 | -1.27 | -1.71 | 3.82 | 4.16 | 1.30 | -0.67 | 3.78 | 2.55 | -4.40 | +1.72% |
| 2023 | -0.19 | -2.26 | -0.73 | 1.15 | -1.18 | -2.43 | -0.31 | -0.51 | -1.63 | -5.81 | 4.68 | 5.01 | -4.59% |
| 2024 | 1.47 | 4.84 | 1.63 | -2.53 | 0.79 | 0.63 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 10.88% | 10.84% | 11.41% | 14.42% | -% |
| Sharpe ratio | 1.22 | 1.73 | -0.06 | 0.07 | - |
| Best month | +5.01% | +5.01% | +5.01% | +6.66% | +10.74% |
| Worst month | -2.53% | -2.53% | -5.81% | -9.64% | -9.64% |
| Maximum loss | -4.95% | -4.95% | -12.94% | -18.83% | - |
| Outperformance | - | - | - | - | - |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,367.2800 | +6.52% | +4.60% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,529.7300 | +6.66% | +4.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 204.7500 | +3.02% | -6.21% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,201.1001 | +3.10% | +14.90% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,588.4700 | +6.18% | +3.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 241.6300 | +3.56% | +12.59% | |
| Candriam Equities L Oncology Imp... | paying dividend | 232.8300 | +5.19% | +0.73% | |
| Candriam Equities L Oncology Imp... | paying dividend | 188.6100 | +6.09% | +3.30% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,379.0000 | +1.22% | +0.36% | |
| Candriam Equities L Oncology Imp... | reinvestment | 155.7100 | +2.98% | +14.51% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,082.6499 | +4.00% | -3.52% | |
| Candriam Equities L Oncology Imp... | reinvestment | 256.1200 | +4.44% | +15.47% | |
| Candriam Equities L Oncology Imp... | reinvestment | 204.2100 | +2.61% | -7.31% | |
| Candriam Equities L Oncology Imp... | reinvestment | 282.8100 | +6.08% | +3.28% | |
| Candriam Equities L Oncology Imp... | reinvestment | 191.2800 | +3.89% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,815.7800 | +3.43% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,843.2800 | +6.18% | +3.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 155.3200 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 270.5100 | +5.19% | +0.71% |
Performance
| YTD | +6.88% | ||
|---|---|---|---|
| 6 Months | +10.66% | ||
| 1 Year | +3.10% | ||
| 3 Years | +14.90% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +46.74% | ||
| Year | |||
| 2023 | -4.59% | ||
| 2022 | +1.72% | ||
| 2021 | +4.39% | ||
